Oncology Clinical Trials in Portland, OR

As of August 2026, 235 paid clinical trials are recruiting for Oncology in Portland, Oregon. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

236 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Portland, OR.

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for Acute Myeloid Leukemia

Drug: Revumenib

Sites in Portland +9 more locations

Sponsor: Syndax Pharmaceuticals

Sex: All·Age: 30 Days+

Code: NCT04065399·Phase 1, Phase 2·Recruiting·Listed Aug 2019

Apply to this trial

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for Endometrial Cancer

Sites in Portland, Eugene +16 more locations

Sponsor: Faeth Therapeutics

Sex: Female·Age: 18+

Code: NCT06463028·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Study of SGR-1505 in Mature B-Cell Neoplasms

for Mature B-Cell Neoplasm

Sites in Portland +15 more locations

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for Renal Cell Carcinoma

Sites in Portland +19 more locations

Sponsor: HiberCell, Inc.

Sex: All·Age: 18+

Code: NCT06234605·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for Advanced or Metastatic Solid Tumors

Sites in Portland +9 more locations

Sponsor: Incendia Therapeutics

Sex: All·Age: 18+

Code: NCT05753722·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Portland +10 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06459973·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for Solid Tumor, Adult

Sites in Portland +12 more locations

Sponsor: GV20 Therapeutics

Sex: All·Age: 18+

Code: NCT05669430·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Study of AVZO-021 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +10 more locations

Sponsor: Avenzo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05867251·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for Brain Cancer

Sites in Portland +15 more locations

Sponsor: Adela, Inc

Sex: All·Age: 40+·Accepts healthy volunteers

Code: NCT05366881·Recruiting·Listed May 2022

Apply to this trial

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for Endometrial Cancer

Sites in Portland, Eugene +17 more locations

Sponsor: Kartos Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT05797831·Phase 2, Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for Colorectal Cancer

Drug: Bevacizumab

Sites in Portland +3 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07525206·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

for Solid Tumor

Sites in Portland +7 more locations

Sponsor: Alyssum Therapeutics

Sex: All·Age: 18+

Code: NCT06234098·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Portland +7 more locations

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Leukemia, Myeloid, Acute

Sites in Portland +5 more locations

Sponsor: Orca Biosystems, Inc.

Sex: All·Age: 18+

Code: NCT07216443·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

for Brain Tumor

Sites in Portland +7 more locations

Sponsor: InSightec

Sex: All·Age: 18 - 100

Code: NCT05317858·Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +6 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05875168·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

SW-682 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +7 more locations

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All·Age: 18+

Code: NCT06251310·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

for Epithelial Ovarian Cancer

Drug: IMNN-001

Sites in Portland +7 more locations

Sponsor: Imunon

Sex: Female·Age: 18+

Code: NCT06915025·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Portland +10 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for Non Hodgkin Lymphoma

Sites in Portland +10 more locations

Sponsor: Miltenyi Biomedicine GmbH

Sex: All·Age: 18+

Code: NCT06116110·Recruiting·Listed Nov 2023

Apply to this trial

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for Prostate Adenocarcinoma

Sites in Portland +9 more locations

Sponsor: Alessa Therapeutics Inc.

Sex: Male·Age: 21+

Code: NCT06257693·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

for Carcinoma, Non-small-Cell Lung

Sites in Portland +6 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18+

Code: NCT06116786·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for Small Cell Lung Cancer

Drug: Gocatamig

Sites in Portland +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06780137·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

Sites in Portland +7 more locations

Sponsor: MOMA Therapeutics

Sex: All·Age: 18+

Code: NCT06974110·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Portland +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for Hepatocellular Carcinoma

Sites in Portland +4 more locations

Sponsor: Eureka Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT04864054·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for NSCLC (Advanced Non-small Cell Lung Cancer)

Sites in Portland +7 more locations

Sponsor: ALX Oncology Inc.

Sex: All·Age: 18+

Code: NCT07085091·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

for Chronic Myelomonocytic Leukemia

Sites in Portland +6 more locations

Sponsor: Solu Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06950034·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +3 more locations

Sponsor: Ankyra Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06171750·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

for Solid Tumor

1 location in Portland

Sponsor: Axcynsis Therapeutics Pte Ltd

Sex: All·Age: 18+

Code: NCT06809114·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for Non-Hodgkin Lymphoma

Sites in Portland +2 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: All ages

Code: NCT06357754·Recruiting·Listed Apr 2024

Apply to this trial

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for Gastrointestinal Stromal Tumors

Sites in Portland +3 more locations

Sponsor: Novelty Nobility, Inc.

Sex: All·Age: 18+

Code: NCT06805825·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

for Acute Myeloid Leukemia

Drug: Ruxolitinib

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+

Code: NCT07548983·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for Chronic Lymphocytic Leukemia

Drug: Sonrotoclax

Sites in Portland, Oregon City +179 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 65+

Code: NCT07321652·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

for Prostate Carcinoma

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: Male·Age: 65+

Code: NCT07504835·Recruiting·Listed Apr 2026

Apply to this trial

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

for Advanced Biliary Tract Carcinoma

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+

Code: NCT07405086·Phase 4·Recruiting·Listed Feb 2026

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

Sites in Portland, Newberg +628 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in Portland, Oregon City +1098 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Conditions in Oncology (Portland, OR)

Solid tumor· 43 Non-small cell lung cancer (NSCLC)· 34 Breast cancer· 22 Acute myeloid leukemia (AML)· 20 Prostate cancer· 19 Cancer (any)· 18 Endometrial cancer· 17 Colorectal cancer· 16 Ovarian cancer· 16 Melanoma· 14 Hematologic malignancy· 13 Multiple myeloma· 11 Leukemia (other)· 11 Non-Hodgkin lymphoma· 11 Myelodysplastic syndromes (MDS)· 10 Diffuse large B-cell lymphoma (DLBCL)· 10 Head and neck cancer· 9 Pancreatic cancer· 8 Fallopian tube cancer· 8 Metastatic prostate cancer· 7 Chronic lymphocytic leukemia (CLL)· 7 Lung cancer· 6 Gastric cancer· 6 Bladder cancer· 6 Cervical cancer· 6 Mantle cell lymphoma· 6 Neuroblastoma· 6 Esophageal cancer· 5 Follicular lymphoma· 5 Metastatic breast cancer· 4 Triple-negative breast cancer· 4 Gastroesophageal junction cancer· 4 Kidney cancer· 4 Acute lymphoblastic leukemia· 4 Myelofibrosis· 4 Myeloproliferative neoplasm· 4 Small lymphocytic lymphoma· 4 HER2-positive breast cancer· 3 HER2-negative breast cancer· 3 Small cell lung cancer· 3 Rectal cancer· 3 Liver cancer· 3 Biliary tract cancer· 3 Chronic myelomonocytic leukemia· 3 Hodgkin lymphoma· 3 Burkitt lymphoma· 3 Thyroid cancer· 3 Sarcoma· 3 Metastatic colorectal cancer· 2 Colon cancer· 2 Glioma· 2 Brain cancer· 2 Marginal zone lymphoma· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Mesothelioma· 2 Neuroendocrine tumors· 2 Uterine cancer· 1 Glioblastoma· 1 Brain metastases· 1 Rhabdomyosarcoma· 1 Pediatric cancer· 1